Recombinant multi-species DNAH5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DNAH5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
The Alternative Names of target: Axonemal beta dynein heavy chain 5,CILD3,Ciliary dynein heavy chain 5,DLP5,DNAH5,DNAHC5,Dnah5,Dnahc5,Dnahc8,Dynein axonemal heavy chain 5,HL1,KTGNR,Mdnah5,PCD,b2b1134Clo,b2b1154Clo,b2b1537Clo,b2b1565Clo,b2b3491Clo,b2b601Clo,mKIAA1603

Target products collectionGo to DNAH5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6222-Ag-1/ GM-Tg-hg-IP6222-Ag-2 Human DNAH5 protein Human
GM-Tg-rg-IP6222-Ag-1/ GM-Tg-rg-IP6222-Ag-2 Rat DNAH5 protein Rat
GM-Tg-mg-IP6222-Ag-1/ GM-Tg-mg-IP6222-Ag-2 Mouse DNAH5 protein Mouse
GM-Tg-cynog-IP6222-Ag-1/ GM-Tg-cynog-IP6222-Ag-2 Cynomolgus/Rhesus macaque DNAH5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6222-Ag-1/ GM-Tg-felg-IP6222-Ag-2 Feline DNAH5 protein Feline
GM-Tg-cang-IP6222-Ag-1/ GM-Tg-cang-IP6222-Ag-2 Canine DNAH5 protein Canine
GM-Tg-bovg-IP6222-Ag-1/ GM-Tg-bovg-IP6222-Ag-2 Bovine DNAH5 protein Bovine
GM-Tg-equg-IP6222-Ag-1/ GM-Tg-equg-IP6222-Ag-2 Equine DNAH5 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6222-Ag-1/ GM-Tg-hg-IP6222-Ag-2; GM-Tg-rg-IP6222-Ag-1/ GM-Tg-rg-IP6222-Ag-2;
GM-Tg-mg-IP6222-Ag-1/ GM-Tg-mg-IP6222-Ag-2; GM-Tg-cynog-IP6222-Ag-1/ GM-Tg-cynog-IP6222-Ag-2;
GM-Tg-felg-IP6222-Ag-1/ GM-Tg-felg-IP6222-Ag-2; GM-Tg-cang-IP6222-Ag-1/ GM-Tg-cang-IP6222-Ag-2;
GM-Tg-bovg-IP6222-Ag-1/ GM-Tg-bovg-IP6222-Ag-2; GM-Tg-equg-IP6222-Ag-1/ GM-Tg-equg-IP6222-Ag-2
Products Name DNAH5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DNAH5
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DNAH5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.